Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
West Indian med. j ; 47(1): 18-22, Mar. 1998.
Article in English | LILACS | ID: lil-473427

ABSTRACT

This paper reports on neurological and neurosurgical referrals overseas from the Queen Elizabeth Hospital (QEH) for the period November 1987 to November 1996, and is a follow up to an earlier report for the period January 1984 to November 1987. It outlines the pattern of referral, diagnoses, referral centres and costs based on examination of the files of all QEH patients transferred overseas under a government aided scheme. There were 203 transfers of 191 patients (69 males, 122 females) including 10 patients who were transferred twice and one patient who was transferred three times. Patients' ages ranged from 1 to 80 years (mean 37 years). Twenty overseas centres were used during the period but most patients were transferred to Brooklyn Hospital, New York in 1988, Mount Sinai Medical Center, New York, between 1989 and 1994, and Hospital de Clinicas Caracas, Venezuela (1992 to 1996). 65of the referrals were for neurosurgery and 25were for magnetic resonance imaging scans for diagnosis. The largest diagnostic categories were central nervous system tumors (40) and subarachnoid haemorrhage (25). Estimated costs reached almost BDS$11 million, but the mean actual cost was BDS$63,916 based on information from 123 patient transfers. Thus, the actual total government expenditure was probably closer to BDS$13 million. This study demonstrates the urgent need to establish a neurosurgical service at the QEH and the cost effectiveness of doing so.


Subject(s)
Humans , Male , Female , Neurosurgery/statistics & numerical data , Neurology/statistics & numerical data , Referral and Consultation/statistics & numerical data , Patient Transfer/statistics & numerical data , Cost-Benefit Analysis , Barbados , Health Expenditures/statistics & numerical data , Hospitals, General/economics , Hospitals, General/statistics & numerical data , Neurosurgery/economics , Neurology/economics , Referral and Consultation/economics , Patient Transfer/economics
2.
West Indian med. j ; 41(1): 15-8, Mar. 1992.
Article in English | LILACS | ID: lil-107503

ABSTRACT

The main features of the Neuroleptic Malignant Syndrome (NMS), a complication of neuroleptic therapy, are fever, muscle rigidity, autonomic dysfunction, and an alteration in consciousness level. We describe five cases of NMS comprising 0.6 per cent of acute neuroleptically-treated admissions to a psychiatric hospital over a one-year period. All patients, four females aged 26 to 63 years, and one male, aged 65 years, were of African origin and received multiple neuroleptic drugs, at least one of which was a depot preparation. Four were being treated for functional psychiatric disorders while one had dementia. All patients had fever and depressed consciousness level while four had rigidity and autonomic dysfunction. Serum creatine phosphokinase was elevated in 4 cases, and there was indirect evidence of myoglobinuria in 3 cases suggested by a positive urine dipstick test for blood despite the absence of red cells on microscopy. Rhabdomyolysis was associated with renal failure in one case. Both bromocriptine mesylate and dantrolene sodium were given in two cases. Three patients died in hospital, one with persistent rigidity and progressive decubitus ulceration, one from peritonitis following dialysis, and another suddenly. Early recognition of NMS is important; it should be considered in any patient on neuroleptic therapy who develops fever, rigidity or alteration in consciousness level.


Subject(s)
Antipsychotic Agents/complications , Neuroleptic Malignant Syndrome , Risk Assessment , Neuroleptic Malignant Syndrome/complications , Neuroleptic Malignant Syndrome/diagnosis , Neuroleptic Malignant Syndrome/etiology
SELECTION OF CITATIONS
SEARCH DETAIL